Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines
- PMID: 16093438
- DOI: 10.1158/1535-7163.MCT-04-0186
Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines
Abstract
The antitumor activity of the histone deacetylase inhibitors was tested in three well-characterized pancreatic adenocarcinoma cell lines, IMIM-PC-1, IMIM-PC-2, and RWP-1. These cell lines have been previously characterized in terms of their origin, the status of relevant molecular markers for this kind of tumor, resistance to other antineoplastic drugs, and expression of differentiation markers. In this study, we report that histone deacetylase inhibitors induce apoptosis in pancreatic cancer cell lines, independently of their intrinsic resistance to conventional antineoplastic agents. The histone deacetylase inhibitor-induced apoptosis is due to a serine protease-dependent and caspase-independent mechanism. Initially, histone deacetylase inhibitors increase Bax protein levels without affecting Bcl-2 levels. Consequently, the apoptosis-inducing factor (AIF) and Omi/HtrA2 are released from the mitochondria, with the subsequent induction of the apoptotic program. These phenomena require AIF relocalization into the nuclei to induce DNA fragmentation and a serine protease activity of Omi/HtrA2. These data, together with previous results from other cellular models bearing the multidrug resistance phenotype, suggest a possible role of the histone deacetylase inhibitors as antineoplastic agents for the treatment of human pancreatic adenocarcinoma.
Comment in
-
Serine proteases in histone deacetylase inhibitor-induced apoptosis.Mol Cancer Ther. 2010 Aug;9(8):2440-1; author reply 2441-2. doi: 10.1158/1535-7163.MCT-09-0512. Epub 2010 Aug 3. Mol Cancer Ther. 2010. PMID: 20682651 No abstract available.
Similar articles
-
The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells.Mol Cancer Ther. 2004 Apr;3(4):425-35. Mol Cancer Ther. 2004. PMID: 15078986
-
Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization.EMBO J. 2003 Sep 1;22(17):4385-99. doi: 10.1093/emboj/cdg423. EMBO J. 2003. PMID: 12941691 Free PMC article.
-
Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA).J Biol Chem. 2003 Apr 4;278(14):12579-89. doi: 10.1074/jbc.M213093200. Epub 2003 Jan 29. J Biol Chem. 2003. PMID: 12556448
-
The histone deacetylase inhibitor suberic bishydroxamate: a potential sensitizer of melanoma to TNF-related apoptosis-inducing ligand (TRAIL) induced apoptosis.Biochem Pharmacol. 2003 Oct 15;66(8):1537-45. doi: 10.1016/s0006-2952(03)00509-4. Biochem Pharmacol. 2003. PMID: 14555232 Review.
-
Histone deacetylase inhibitors in programmed cell death and cancer therapy.Cell Cycle. 2005 Apr;4(4):549-51. doi: 10.4161/cc.4.4.1564. Epub 2005 Apr 28. Cell Cycle. 2005. PMID: 15738652 Review.
Cited by
-
The role of the mitochondria in mediating cytotoxicity of anti-cancer therapies.J Bioenerg Biomembr. 2007 Feb;39(1):13-21. doi: 10.1007/s10863-006-9055-9. J Bioenerg Biomembr. 2007. PMID: 17294132 Review.
-
PDGFR and IGF-1R Inhibitors Induce a G2/M Arrest and Subsequent Cell Death in Human Glioblastoma Cell Lines.Cells. 2018 Sep 6;7(9):131. doi: 10.3390/cells7090131. Cells. 2018. PMID: 30200644 Free PMC article.
-
Targeting histone deacetylases in pancreatic ductal adenocarcinoma.J Cell Mol Med. 2010 Jun;14(6A):1255-63. doi: 10.1111/j.1582-4934.2009.00974.x. Epub 2009 Nov 19. J Cell Mol Med. 2010. PMID: 19929947 Free PMC article. Review.
-
Molecular determinants of the antitumor effects of trichostatin A in pancreatic cancer cells.World J Gastroenterol. 2010 Apr 28;16(16):1970-8. doi: 10.3748/wjg.v16.i16.1970. World J Gastroenterol. 2010. PMID: 20419833 Free PMC article.
-
Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3.Cell Death Dis. 2013 Jun 6;4(6):e655. doi: 10.1038/cddis.2013.192. Cell Death Dis. 2013. PMID: 23744355 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials